A Study Comparing Two Forms of Didanosine in HIV-infected Patients

Summary

The purpose of this study is to see if the coated-capsule form of didanosine (ddI) is as safe and absorbed by the body as well as the chewable-tablet form of ddI. Didanosine (ddI) is an anti-HIV drug. The effectiveness of ddI can be lowered by acid in the stomach. To prevent this, patients take antacids with ddI. The coated-capsule form of ddI may replace the need for antacids.

Timeline

Start

1999-03

Primary completion

1999-03

Completion

1999-03

Drugs

Indications